Rescuing Cows from Mastitis and Acidosis
89%
$26K
66%
UNH
A Herd in Crisis
In May 2022, Vosberg Valley View Farm (VVV) faced a wave of toxic mastitis that threatened to devastate their herd. Feed changes and weather fluctuations disrupted the cows’ systems, and when robotic milking equipment was introduced in June 2022, the stress compounded quickly.
The farm was soon managing sick cows every week. Milk production dropped sharply, cows were dying, and the underlying cause — subclinical acidosis — was quietly making the whole herd more vulnerable to secondary illness.
Without intervention, toxic mastitis carried an overwhelming death rate. Cows that survived were often too compromised to return to the milking herd — leaving VVV absorbing the full cost of replacement.
0% of cows with toxic mastitis recovered to full production without an intervention protocol in place.
A Whole-Herd Approach
VVV needed an approach that could support recovery at scale, keep sick cows eating and ruminating, and work alongside dietary changes — without adding pharmaceutical burden to an already compromised immune system.
They turned to MagnaWave PEMF. Used alongside adjustments to reduce dietary starch and increase fiber, MagnaWave sessions were incorporated into the care protocol for every cow that showed signs of mastitis or secondary illness due to acidosis.
Supports Circulation
MagnaWave promotes increased circulation, supporting the body’s natural processes at the cellular level.
Non-Invasive
No drugs, no needles. MagnaWave is a drug-free, non-invasive PEMF modality that works with veterinary care.
Supports Recovery
Cows on MagnaWave maintained eating and rumination function during illness — a key factor in preserving body condition and resilience.
The Numbers Tell the Story
VVV tracked outcomes across 18 head of Normande Cattle — comparing cows that received MagnaWave as part of their care protocol against those that did not.
WITH MAGNAWAVE
WITHOUT MAGNAWAVE
DIFFERENCE
Financial Impact Per 100 Head
| Death Loss | Sold | Replacement Cost | Total | |
|---|---|---|---|---|
| With MagnaWave | $(1,333) | $2,667 | $(11,667) | $(10,333) |
| Without MagnaWave | $(6,667) | $5,333 | $(35,000) | $(36,333) |
$26,000
The combined effect of reduced death loss, more cows sold with body condition, and dramatically lower replacement costs produced a measurable, sustained economic advantage for VVV.
From 56% Deaths to 89% Recovery
MagnaWave didn’t just slow the bleeding — it changed the outcome entirely. Cows that had been dying now left the farm on their own feet, with body condition, loaded onto trailers as recoveries rather than casualties. Cows that recovered went back to work in the milking herd.
VVV has since established new internal protocols combining MagnaWave with herd-specific dietary management. The results set a new benchmark for how dairy operations can approach toxic mastitis and acidosis-related illness.
89%
Recovery rate for toxic mastitis cows — up from near zero
66%
Of recovered cows returned to active milk production
11%
Death loss with MagnaWave — compared to 56% in the control group
What the Science Shows
The results at Vosberg Valley View Farm weren’t a fluke. MagnaWave partnered with the University of New Hampshire to study PEMF’s effects on dairy cattle in a controlled research setting — measuring the indicators that matter most to producers: udder health, inflammation, and milk production.
The UNH study enrolled 35 Jersey cows in three groups — control, once-daily PEMF, and twice-daily PEMF — across a 10-day protocol: a 2-day baseline, 3 days of daily sessions, and a 5-day follow-up.
Mastitis costs U.S. dairy farmers an estimated $2 billion every year in lost production, discarded milk, and replacement animals. For organic operations, the challenge is even greater — antibiotics aren’t an option, leaving producers with few effective tools.
University of New Hampshire
Independent university research partnership with MagnaWave
35 Jersey Cows
Divided into control, once-daily PEMF, and twice-daily PEMF groups with comparable baselines
4 Key Markers
Milk yield, milk composition (fat, protein, lactose), somatic cell count, and blood inflammation markers
Somatic Cell Count Decreased
PEMF-treated cows showed a significant reduction in somatic cell count (SCC) compared to the control group — a direct indicator of improved udder health and reduced subclinical mastitis. The reduction persisted even after daily sessions ended.
A Specific Udder-Health Signal
The improvement showed up in the measure that matters most to producers: somatic cell count. Blood markers remained within normal ranges throughout the study, consistent with the healthy status of the enrolled cows.
Milk Production Maintained
PEMF did not reduce milk yield or change milk components — fat, protein, and lactose all held steady. The udder-health improvement came at no cost to productivity or milk quality.
Benefits Lasted Beyond Treatment
Follow-up data showed that improvements in SCC and inflammation markers largely held after active sessions stopped — suggesting a sustained positive effect on the cows' overall wellness and resilience.
01
Under 15 Minutes
Each session takes 10 to 12 minutes per cow — practical for even busy operations
02
4 Treatment Zones
03
Low Stress
04
Lasting Results
Built for the Field
Semi 10
Julian
Sol Pro
A reliable, self-contained analog machine built for consistent daily use in livestock and equine settings.